Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Run-Ling Wang

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
Acta Crystallographica. Section E, Structure Reports Online|May 19, 2011
3-Bromo-1-(3-chloro-pyridin-2-yl)-N-(4-eth-oxy-phen-yl)-1H-pyrazole-5-carbox-amideHai Yue, Wei-Li Dong, Run-Ling Wang, et al.
Acta Crystallographica. Section E, Structure Reports Online|May 17, 2012
Poly[[bis-(μ-4,4'-bipyridine-κ(2)N:N')copper(I)] perchlorate 0.24-hydrate]Chun-Yan Zhang, Xue-Jun Yao, Run-Ling Wang, et al.
Acta Crystallographica. Section E, Structure Reports Online|December 27, 2011
Ethyl 4-[(4-chloro-phen-oxy)meth-yl]-2-(4-nitro-phen-yl)-1,3-thia-zole-5-carboxyl-ateZhi-Rong Deng, Shu-Qing Wang, Wei-Li Dong, et al.
Acta Crystallographica. Section E, Structure Reports Online|May 19, 2011
3-Hy-droxy-methyl-1-(4-meth-oxy-phen-yl)imidazolidine-2,4-dioneXian-Chao Cheng, Jing-Jing Hou, Run-Ling Wang, et al.
Acta Crystallographica. Section E, Structure Reports Online|May 19, 2011
Methyl 4-(cyclopropylmethoxy)-3-hydroxybenzoate [corrected]Jing-Jing Hou, Xian-Chao Cheng, Run-Ling Wang, et al.
Chemical Biology & Drug Design|June 19, 2016
Multitargeted bioactive ligands for PPARs discovered in the last decadeJun Zhang, Xin Liu, Xian-Bin Xie, et al.
Journal of Biomolecular Structure & Dynamics|May 3, 2019
Probing the acting mode and advantages of RMC-4550 as an Src-homology 2 domain-containing protein tyrosine phosphatase (SHP2) inhibitor at molecular level through molecular docking and molecular dynamicsRui-Rui Wang, Wen-Shan Liu, Liang Zhou, et al.
Plos One|June 12, 2012
Design novel dual agonists for treating type-2 diabetes by targeting peroxisome proliferator-activated receptors with core hopping approachYing Ma, Shu-Qing Wang, Wei-Ren Xu, et al.
Computational Biology and Chemistry|March 2, 2018
Scaffold-based novel SHP2 allosteric inhibitors design using Receptor-Ligand pharmacophore model, virtual screening and molecular dynamicsWen-Yan Jin, Ying Ma, Wei-Ya Li, et al.
Computational Biology and Chemistry|September 28, 2019
Exploring the effect of aplidin on low molecular weight protein tyrosine phosphatase by molecular docking and molecular dynamic simulation studyYing-Zhan Sun, Jing-Wei Wu, Xin-Hua Lu, et al.
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
Acta Crystallographica. Section E, Structure Reports Online|May 19, 2011
3-Bromo-1-(3-chloro-pyridin-2-yl)-N-(4-eth-oxy-phen-yl)-1H-pyrazole-5-carbox-amideHai Yue, Wei-Li Dong, Run-Ling Wang, et al.
Acta Crystallographica. Section E, Structure Reports Online|May 17, 2012
Poly[[bis-(μ-4,4'-bipyridine-κ(2)N:N')copper(I)] perchlorate 0.24-hydrate]Chun-Yan Zhang, Xue-Jun Yao, Run-Ling Wang, et al.
Acta Crystallographica. Section E, Structure Reports Online|December 27, 2011
Ethyl 4-[(4-chloro-phen-oxy)meth-yl]-2-(4-nitro-phen-yl)-1,3-thia-zole-5-carboxyl-ateZhi-Rong Deng, Shu-Qing Wang, Wei-Li Dong, et al.
Acta Crystallographica. Section E, Structure Reports Online|May 19, 2011
3-Hy-droxy-methyl-1-(4-meth-oxy-phen-yl)imidazolidine-2,4-dioneXian-Chao Cheng, Jing-Jing Hou, Run-Ling Wang, et al.
Acta Crystallographica. Section E, Structure Reports Online|May 19, 2011
Methyl 4-(cyclopropylmethoxy)-3-hydroxybenzoate [corrected]Jing-Jing Hou, Xian-Chao Cheng, Run-Ling Wang, et al.
Chemical Biology & Drug Design|June 19, 2016
Multitargeted bioactive ligands for PPARs discovered in the last decadeJun Zhang, Xin Liu, Xian-Bin Xie, et al.
Journal of Biomolecular Structure & Dynamics|May 3, 2019
Probing the acting mode and advantages of RMC-4550 as an Src-homology 2 domain-containing protein tyrosine phosphatase (SHP2) inhibitor at molecular level through molecular docking and molecular dynamicsRui-Rui Wang, Wen-Shan Liu, Liang Zhou, et al.
Plos One|June 12, 2012
Design novel dual agonists for treating type-2 diabetes by targeting peroxisome proliferator-activated receptors with core hopping approachYing Ma, Shu-Qing Wang, Wei-Ren Xu, et al.
Computational Biology and Chemistry|March 2, 2018
Scaffold-based novel SHP2 allosteric inhibitors design using Receptor-Ligand pharmacophore model, virtual screening and molecular dynamicsWen-Yan Jin, Ying Ma, Wei-Ya Li, et al.
Computational Biology and Chemistry|September 28, 2019
Exploring the effect of aplidin on low molecular weight protein tyrosine phosphatase by molecular docking and molecular dynamic simulation studyYing-Zhan Sun, Jing-Wei Wu, Xin-Hua Lu, et al.
Pageof 6